 |
 |

Modes of Transmission of Hemorrhagic Fever
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In their Consensus Statement on hemorrhagic fever viruses that may be used as biological weapons, Dr Borio and colleagues1 state, "There are no reported cases of person-to-person or nosocomial spread of flaviviruses." At least 2 cases of nosocomial transmission of dengue (a flavivirus) have been reported in the medical literature: one through a needlestick injury2 and the other through bone marrow transplantation.3 These events, although rare, suggest that nosocomial spread may also be possible for a more feared flavivirusyellow fever.
José G. Rigau-Pérez, MD,MPH
Dengue Branch, Division of Vector-Borne Infectious Diseases National Center for Infectious Diseases Centers for Disease Control and Prevention San Juan, Puerto Rico
1. Borio L, Inglesby T, Peters CJ, et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA. 2002;287:2391-2405.
FREE FULL TEXT
2. de Wazières B, Gil H, Vuitton DA, Dupond JL. Nosocomial transmission of dengue from a needlestick injury. Lancet. 1998;351:498.
PUBMED
3. Rigau-Pérez JG, Vorndam AV, Clark GG. The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995. Am J Trop Med Hyg. 2001;64:67-74.
ABSTRACT
To the Editor: In their Consensus Statement, Dr Borio and colleagues1 briefly mention Kyasanur Forest disease virus (KFDV), which occurs in a remote part of the world. In 1957, 2 of my colleagues and I were accidentally infected with KFDV while . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Hemorrhagic Fever Viruses as Biological Weapons: Medical and Public Health Management
Luciana Borio, Thomas Inglesby, C. J. Peters, Alan L. Schmaljohn, James M. Hughes, Peter B. Jahrling, Thomas Ksiazek, Karl M. Johnson, Andrea Meyerhoff, Tara O'Toole, Michael S. Ascher, John Bartlett, Joel G. Breman, Edward M. Eitzen, Jr, Margaret Hamburg, Jerry Hauer, D. A. Henderson, Richard T. Johnson, Gigi Kwik, Marci Layton, Scott Lillibridge, Gary J. Nabel, Michael T. Osterholm, Trish M. Perl, Philip Russell, Kevin Tonat, and for the Working Group on Civilian Biodefense
JAMA. 2002;287(18):2391-2405.
ABSTRACT
| FULL TEXT
|